{
  "id": "a16z:scribe-therapeutics",
  "a16z_company_id": "371926",
  "name": "Scribe Therapeutics",
  "slug": "scribe-therapeutics",
  "description": "Portfolio of genetic medicines for cardiometabolic disease using proprietary, engineered gene editing and epigenetic silencing platforms",
  "website": "https://Scribetx.com",
  "status": "active",
  "sectors": [
    "bio-health"
  ],
  "stages": [
    "seed",
    "venture"
  ],
  "source_urls": {
    "investment_list": "https://a16z.com/investment-list/",
    "portfolio": "https://a16z.com/portfolio/"
  },
  "source_evidence": {
    "in_investment_list": true,
    "in_portfolio": true
  },
  "first_seen_iso": "2026-02-22T06:35:06Z",
  "last_seen_iso": "2026-02-22T06:35:06Z"
}
